Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

NCT01357980 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Detrusor Muscle Hyperactivity

Interventions

BIOLOGICAL: Botulinum toxin type A
DRUG: Placebo

Sponsor

Ipsen